Analyst Consensus ?
ConsensusHold52 ratings
Bullish2344.2%
Neutral2853.9%
Bearish11.9%
Marriott International, Inc. · MAR · FY2026 Q2 · Calendar Q3 2026
Marriott raises RevPAR outlook as growth initiatives expand
Marriott's Q2 update supports a constructive operating picture: RevPAR outperformed, rooms growth remained strong and management raised its full-year RevPAR outlook. The thesis is balanced by higher planned investment, execution questions around new initiatives, and Middle East and currency risks.
Reported Before market openNASDAQConsumer Cyclical
$90.76B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$3.19
Consensus $3.08
EPS surprise
+3.6%
Reported versus consensus
Reported revenue
$7.07B
Consensus $7.19B
Revenue surprise
-1.7%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-7.0%
Event window
SPY move
+1.4%
Same window
Abnormal move
-8.4%
Stock minus SPY
Volume
3.2×
Versus trailing sessions
Subsequent drift
-1.5%
Up to 20 sessions
MARSPY benchmark
Ask FN2 about MAR FY2026 Q2
Transcript, numbers and history already loaded
Why did MAR fall 7.0% after beating EPS estimates in FY2026 Q2?What changed in MAR's guidance and outlook in FY2026 Q2?Give me the bull and bear case for MAR after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, Marriott reported Q2 global RevPAR growth of 3.4% and raised full-year RevPAR guidance to 3%-3.5%. The call also added detail on Series by Marriott in Greater China, the ITR owner incentive, Ask Bonvoy and new co-branded card economics, while capex increased to $1.25-$1.35 billion.
Guidance delta
Full-year global RevPAR guidance was raised to 3%-3.5%.
Key takeaways
- Q2 global RevPAR increased 3.4%, while U.S./Canada RevPAR rose 5%.
- Net rooms grew 4.5% year over year to more than 1.8 million, supported by signings and conversions.
- The record pipeline reached 629,000 rooms, with conversions representing 34% of signings.
- Management highlighted Series by Marriott in Greater China, the ITR owner incentive, co-branded cards and Ask Bonvoy.
- The company plans $1.25-$1.35 billion of capex focused on digital transformation, key money and renovations.
Management priorities
- Roll out the Series by Marriott collection across Greater China.
- Implement the ITR incentive for owners in the back half of 2026.
- Continue AI integration with Ask Bonvoy and expand partnerships with Google.
- Maintain pipeline growth through conversions and new signings.
- Return over $4.5 billion to shareholders via share repurchases and dividends.
Follow MAR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$348.06Current
$160Low
$326.29Average
$449High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Sep 10, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 20, 2026 |
| Macquarie | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 4, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 4, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 4, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 4, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 21, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 21, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 17, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Apr 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 11, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 11, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jan 15, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 16, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 21, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 1, 2024 |
| Credit Suisse | Hold | Hold | Maintain | Feb 16, 2023 |
| Redburn Partners | Sell | Sell | Maintain | Nov 30, 2022 |
| Berenberg | Buy | Hold | Upgrade | Sep 15, 2022 |
| Loop Capital | Hold | Hold | Maintain | Feb 16, 2022 |
| Gordon Haskett | Hold | Hold | Maintain | Jun 26, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | Jun 23, 2020 |
| Nomura | Buy | Buy | Maintain | Jun 23, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 13, 2020 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Mar 30, 2020 |
| CFRA | Hold | Hold | Maintain | Feb 28, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 27, 2020 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 7, 2020 |
| Longbow Research | Neutral | Underperform | Upgrade | Jul 15, 2019 |
| Argus | Hold | Buy | Downgrade | Nov 20, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 23, 2018 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 30, 2017 |
| Guggenheim | Neutral | Neutral | Maintain | Apr 26, 2017 |
| MKM Partners | Buy | Neutral | Upgrade | Dec 5, 2016 |
| Canaccord Genuity | Buy | Buy | Maintain | Mar 23, 2016 |
| Telsey Advisory Group | Perform | Market Perform | Maintain | Jan 4, 2016 |
| Brean Capital | Hold | Hold | Maintain | Jun 25, 2015 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 19, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Sep 9, 2014 |
| Bank of America | Buy | Buy | Maintain | Jan 13, 2014 |
| Oddo Securities | Neutral | Reduce | Upgrade | Jul 2, 2013 |
| ISI Group | Buy | Neutral | Upgrade | Jun 3, 2013 |
| Evercore Partners | Overweight | Overweight | Maintain | May 29, 2013 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Jan 14, 2013 |
| McNicoll Lewis Vlak | Hold | Hold | Maintain | Oct 5, 2012 |
| Keefe, Bruyette & Woods | Market Perform | Outperform | Downgrade | Sep 26, 2012 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Sep 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $348.06. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $360 | $332.84 | +3.4% | Sep 10, 2026 |
| UBS | Robin Farley | $395 | $359.95 | +13.5% | Aug 20, 2026 |
| Deutsche Bank | Analyst unavailable | $372 | $344.7 | +6.9% | Aug 4, 2026 |
| Robert W. Baird | Analyst unavailable | $393 | $346.83 | +12.9% | Aug 4, 2026 |
| Barclays | Brandt Montour | $348 | $346.83 | -0.0% | Aug 4, 2026 |
| BMO Capital | Analyst unavailable | $395 | $346.83 | +13.5% | Aug 3, 2026 |
| Stifel Nicolaus | Simon Yarmak | $343 | $345.78 | -1.5% | Aug 3, 2026 |
| Barclays | Analyst unavailable | $379 | $366.24 | +8.9% | Jul 20, 2026 |
| Wells Fargo | Analyst unavailable | $449 | $369.05 | +29.0% | Jul 16, 2026 |
| Bernstein | Analyst unavailable | $412 | $402.79 | +18.4% | Jun 15, 2026 |
| UBS | Analyst unavailable | $412 | $402.54 | +18.4% | Jun 15, 2026 |
| Bernstein | Analyst unavailable | $402 | $353.47 | +15.5% | May 15, 2026 |
| Morgan Stanley | Analyst unavailable | $353 | $354.77 | +1.4% | May 12, 2026 |
| Wells Fargo | Analyst unavailable | $446 | $355.54 | +28.1% | May 7, 2026 |
| Argus Research | John Staszak | $425 | $354.67 | +22.1% | May 7, 2026 |
| Deutsche Bank | Steven Pizzella | $376 | $354.87 | +8.0% | May 7, 2026 |
| Mizuho Securities | Analyst unavailable | $384 | $359.06 | +10.3% | May 7, 2026 |
| Robert W. Baird | Analyst unavailable | $386 | $359.06 | +10.9% | May 7, 2026 |
| Barclays | Analyst unavailable | $376 | $359.06 | +8.0% | May 7, 2026 |
| Evercore ISI | Analyst unavailable | $400 | $367.08 | +14.9% | Apr 24, 2026 |
| Susquehanna | Christopher Stathoulopoulos | $385 | $367.13 | +10.6% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $372 | $363.74 | +6.9% | Apr 16, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $354.2 | +0.6% | Apr 10, 2026 |
| Truist Financial | Patrick Scholes | $350 | $366.67 | +0.6% | Feb 11, 2026 |
| Evercore ISI | Analyst unavailable | $385 | $366.5 | +10.6% | Feb 11, 2026 |
| Mizuho Securities | Ben Chaiken | $343 | $359.35 | -1.5% | Feb 11, 2026 |
| Goldman Sachs | Lizzie Dove | $398 | $358.15 | +14.3% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $358 | $359.35 | +2.9% | Feb 11, 2026 |
| BMO Capital | Analyst unavailable | $400 | $359.35 | +14.9% | Feb 10, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $320.56 | +0.6% | Jan 22, 2026 |
| Morgan Stanley | Stephen Grambling | $328 | $325.79 | -5.8% | Jan 16, 2026 |
| Barclays | Brandt Montour | $320 | $325.79 | -8.1% | Jan 16, 2026 |
| BMO Capital | Analyst unavailable | $370 | $324.91 | +6.3% | Jan 9, 2026 |
| Bernstein | Analyst unavailable | $369 | $314.95 | +6.0% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $276 | $305.97 | -20.7% | Dec 17, 2025 |
| Goldman Sachs | Lizzie Dove | $345 | $298.78 | -0.9% | Dec 15, 2025 |
| Truist Financial | Patrick Scholes | $283 | $306.65 | -18.7% | Dec 4, 2025 |
| Goldman Sachs | Analyst unavailable | $288 | $281.86 | -17.3% | Nov 5, 2025 |
| Barclays | Brandt Montour | $274 | $272.24 | -21.3% | Nov 5, 2025 |
| Morgan Stanley | Stephen Grambling | $296 | $268.43 | -15.0% | Oct 22, 2025 |
| Barclays | Brandt Montour | $262 | $266.4 | -24.7% | Oct 3, 2025 |
| Argus Research | Analyst unavailable | $310 | $261.8 | -10.9% | Sep 18, 2025 |
| Bernstein | Analyst unavailable | $327 | $262.05 | -6.1% | Sep 17, 2025 |
| Truist Financial | Patrick Scholes | $278 | $265.07 | -20.1% | Sep 3, 2025 |
| Susquehanna | Christopher Stathoulopoulos | $280 | $273.23 | -19.6% | May 16, 2025 |
| Morgan Stanley | Analyst unavailable | $298 | $270.8 | -14.4% | Mar 4, 2025 |
| Evercore ISI | Duane Pfennigwerth | $330 | $290.75 | -5.2% | Feb 4, 2025 |
| Wells Fargo | Daniel Politzer | $285 | $290.75 | -18.1% | Feb 4, 2025 |
| Robert W. Baird | Michael Bellisario | $285 | $290.46 | -18.1% | Feb 3, 2025 |
| BMO Capital | Ari Klein | $265 | $259.66 | -23.9% | Nov 5, 2024 |
| Robert W. Baird | Michael Bellisario | $264 | $259.53 | -24.2% | Nov 5, 2024 |
| Mizuho Securities | Ben Chaiken | $246 | $259.66 | -29.3% | Nov 5, 2024 |
| Goldman Sachs | Lizzie Dove | $280 | $259.66 | -19.6% | Nov 5, 2024 |
| BMO Capital | Ari Klein | $255 | $264.97 | -26.7% | Oct 22, 2024 |
| Robert W. Baird | Michael Bellisario | $258 | $262.57 | -25.9% | Oct 17, 2024 |
| Bank of America Securities | Shaun Kelley | $275 | $253.04 | -21.0% | Sep 27, 2024 |
| Goldman Sachs | Lizzie Dove | $267 | $235.61 | -23.3% | Sep 18, 2024 |
| Bernstein | Richard Clarke | $262 | $231.37 | -24.7% | Aug 29, 2024 |
| Wells Fargo | Daniel Politzer | $238 | $216.12 | -31.6% | Aug 1, 2024 |
| Barclays | Brandt Montour | $240 | $227.3 | -31.0% | Aug 1, 2024 |
| Mizuho Securities | Ben Chaiken | $260 | $237.41 | -25.3% | Apr 23, 2024 |
| Mizuho Securities | Ben Chaiken | $263 | $252.11 | -24.4% | Mar 25, 2024 |
| Morgan Stanley | Stephen W Grambling | $225 | $191.62 | -35.4% | Sep 26, 2023 |
| Jefferies | Analyst unavailable | $184 | $174.96 | -47.1% | Feb 3, 2023 |
| Truist Financial | Analyst unavailable | $205 | $161.44 | -41.1% | Nov 15, 2022 |
| Barclays | Brandt Montour | $170 | $164.07 | -51.2% | Aug 15, 2022 |
| Argus Research | John Staszak | $203 | $154.02 | -41.7% | May 19, 2022 |
| BMO Capital | Ari Klein | $183 | $178.19 | -47.4% | May 5, 2022 |
| Stifel Nicolaus | Simon Yarmak | $180 | $179.38 | -48.3% | May 4, 2022 |
| Morgan Stanley | Analyst unavailable | $182 | $176.28 | -47.7% | May 2, 2022 |
| Truist Financial | Patrick Scholes | $182 | $174.92 | -47.7% | Feb 20, 2022 |
| Morgan Stanley | Thomas Allen | $172 | $183.26 | -50.6% | Feb 16, 2022 |
| Wells Fargo | Dori Kesten | $199 | $181.2 | -42.8% | Feb 15, 2022 |
| Cowen & Co. | Kevin Kopelman | $180 | $156.53 | -48.3% | Dec 7, 2021 |
| Evercore ISI | Steve Sakwa | $160 | $155.02 | -54.0% | Oct 19, 2021 |
Track every rating change on MAR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMarriott International, Inc. is a leading global hospitality firm responsible for managing, franchising, and licensing a wide range of accommodation options, including hotels, residential units, and timeshare resorts, on an international scale. The company segments its extensive operations into North America (covering the U.S. and Canada) and its various international divisions. Under its corporate umbrella, Marriott oversees a diverse collection of esteemed brands, such as JW Marriott, The Ritz-Carlton, W Hotels, Sheraton, Westin, and Courtyard, among many others. As of February 15, 2022, its impressive network encompassed nearly 8,000 properties—specifically 7,989 establishments—operating across 139 countries and territories under 30 distinct hotel brand names. Established in 1927, Marriott International, Inc. maintains its corporate headquarters in Bethesda, Maryland.
Historical context
All MAR earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AZO AutoZone, Inc. | FY2026 Q4 · Calendar Q3 2026 | — | +3.9% | AutoZone pairs record expansion with strong commercial momentum |
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
| TCOM Trip.com Group Limited | FY2026 Q2 · Calendar Q3 2026 | +22.3% | +3.0% | Trip.com pairs international growth with heavier AI investment |
| CASY Casey's General Stores, Inc. | FY2027 Q1 · Calendar Q3 2026 | +8.7% | -14.2% | Casey's Q1: Prepared Food Drives Growth as Fuel Margins Stay Volatile |
| LULU Lululemon Athletica Inc. | FY2026 Q2 · Calendar Q3 2026 | +63.1% | -17.4% | Lululemon lowers FY2026 outlook as North America weakens |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the MAR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-04T14:10:07.306727+00:00
- FN2 earnings calendar · 2026-09-08T01:23:13.784197+00:00
- Polygon adjusted daily market bars · 2026-09-23T05:30:51.164971+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T05:30:51.162183+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.